Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 23, Issue 1, Pages 35-45
Publisher
Bioscientifica
Online
2015-10-20
DOI
10.1530/erc-15-0343
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage
- (2015) A Reeder et al. BRITISH JOURNAL OF CANCER
- Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer
- (2015) Robert J. van Soest et al. EUROPEAN UROLOGY
- Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells
- (2015) Wendy Onstenk et al. EUROPEAN UROLOGY
- Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
- (2015) Jan Kroon et al. PROSTATE
- Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agents
- (2015) Guanyi Zhang et al. Oncotarget
- Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2015) Emmanuel S. Antonarakis et al. JAMA Oncology
- PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells
- (2015) Martin Puhr et al. Oncotarget
- Glucocorticoids and prostate cancer treatment: friend or foe?
- (2014) Bruce Montgomery et al. ASIAN JOURNAL OF ANDROLOGY
- Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer
- (2014) Maria Thadani-Mulero et al. CANCER RESEARCH
- Impact of prednisone on toxicities and survival in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of randomized clinical trials
- (2014) Charity J. Morgan et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors
- (2014) Ning Xie et al. INTERNATIONAL JOURNAL OF CANCER
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucocorticoid Induced Leucine Zipper inhibits apoptosis of cardiomyocytes by doxorubicin
- (2014) David Aguilar et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer
- (2014) Masis Isikbay et al. Hormones & Cancer
- Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
- (2013) Vivek K. Arora et al. CELL
- Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer
- (2013) M. N. Skor et al. CLINICAL CANCER RESEARCH
- Inhibition of Protein Kinase C/Twist1 Signaling Augments Anticancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer
- (2013) M. Shiota et al. CLINICAL CANCER RESEARCH
- Trametenolic Acid B Reverses Multidrug Resistance in Breast Cancer Cells Through Regulating the Expression Level of P-Glycoprotein
- (2013) Qiaoyin Zhang et al. PHYTOTHERAPY RESEARCH
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells
- (2012) Alexander Yemelyanov et al. CELL CYCLE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro
- (2011) A. M. Al-Abd et al. CELL PROLIFERATION
- Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research
- (2011) Anna Golebiewska et al. Cell Stem Cell
- Overcoming Chemotherapy Resistance in Prostate Cancer
- (2011) R. A. Madan et al. CLINICAL CANCER RESEARCH
- Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
- (2011) Amanda J O'Neill et al. Molecular Cancer
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers
- (2011) Russell Z. Szmulewitz et al. PROSTATE
- Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs
- (2009) Catherine Sánchez et al. PROSTATE
- A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones
- (2008) Mary-Ellen Taplin et al. BJU INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now